TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 85 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23 | -99.8% | 630 | -99.7% | 0.00% | -100.0% |
| Q2 2023 | $9,413 | +49.7% | 249,053 | -4.1% | 0.04% | +39.3% |
| Q1 2023 | $6,287 | -19.3% | 259,794 | -3.6% | 0.03% | -26.3% |
| Q4 2022 | $7,795 | -99.9% | 269,601 | -0.6% | 0.04% | -13.6% |
| Q3 2022 | $8,092,000 | -26.7% | 271,264 | -11.2% | 0.04% | -21.4% |
| Q2 2022 | $11,037,000 | -21.6% | 305,395 | -6.4% | 0.06% | -3.4% |
| Q1 2022 | $14,086,000 | -17.2% | 326,427 | -4.1% | 0.06% | -9.4% |
| Q4 2021 | $17,020,000 | -22.1% | 340,361 | -1.1% | 0.06% | -22.9% |
| Q3 2021 | $21,851,000 | -12.6% | 344,023 | -1.0% | 0.08% | -11.7% |
| Q2 2021 | $24,997,000 | -3.5% | 347,377 | -1.1% | 0.09% | -6.9% |
| Q1 2021 | $25,896,000 | -4.3% | 351,092 | -4.7% | 0.10% | -3.8% |
| Q4 2020 | $27,055,000 | +32.0% | 368,522 | -1.4% | 0.10% | +22.1% |
| Q3 2020 | $20,499,000 | -18.3% | 373,739 | -1.0% | 0.09% | -20.4% |
| Q2 2020 | $25,100,000 | +16.2% | 377,476 | +6.9% | 0.11% | -12.9% |
| Q1 2020 | $21,606,000 | -25.0% | 353,040 | +7.8% | 0.12% | -5.3% |
| Q4 2019 | $28,796,000 | +15.5% | 327,493 | -0.9% | 0.13% | +22.4% |
| Q3 2019 | $24,928,000 | -12.6% | 330,448 | -1.0% | 0.11% | -21.9% |
| Q2 2019 | $28,516,000 | -26.8% | 333,793 | -7.4% | 0.14% | -18.5% |
| Q1 2019 | $38,954,000 | +49.2% | 360,414 | +16.8% | 0.17% | +30.2% |
| Q4 2018 | $26,117,000 | -5.6% | 308,588 | +9.7% | 0.13% | +13.2% |
| Q3 2018 | $27,665,000 | +1.4% | 281,413 | +19.3% | 0.11% | -3.4% |
| Q2 2018 | $27,295,000 | +177.4% | 235,930 | +136.8% | 0.12% | +174.4% |
| Q1 2018 | $9,838,000 | -14.0% | 99,643 | -8.8% | 0.04% | -14.0% |
| Q4 2017 | $11,439,000 | +136.3% | 109,257 | +154.4% | 0.05% | +138.1% |
| Q3 2017 | $4,840,000 | +0.9% | 42,951 | +0.4% | 0.02% | -4.5% |
| Q2 2017 | $4,796,000 | +14.4% | 42,799 | +19.0% | 0.02% | +15.8% |
| Q1 2017 | $4,194,000 | -84.2% | 35,975 | -85.8% | 0.02% | -85.3% |
| Q4 2016 | $26,602,000 | -56.9% | 252,698 | -54.7% | 0.13% | -57.7% |
| Q3 2016 | $61,653,000 | -45.8% | 557,896 | -28.6% | 0.30% | -47.6% |
| Q2 2016 | $113,832,000 | +17.5% | 781,782 | +15.6% | 0.58% | +19.0% |
| Q1 2016 | $96,916,000 | +19.2% | 676,567 | +28.6% | 0.49% | +15.1% |
| Q4 2015 | $81,323,000 | +24.0% | 526,212 | +14.7% | 0.42% | +18.7% |
| Q3 2015 | $65,577,000 | +19.8% | 458,911 | +20.4% | 0.36% | +34.6% |
| Q2 2015 | $54,761,000 | +9.3% | 381,108 | +7.3% | 0.27% | +15.2% |
| Q1 2015 | $50,104,000 | +1.0% | 355,265 | +6.2% | 0.23% | +4.5% |
| Q4 2014 | $49,593,000 | +34.4% | 334,671 | +39.6% | 0.22% | +24.2% |
| Q3 2014 | $36,898,000 | +47.2% | 239,811 | +34.1% | 0.18% | +45.9% |
| Q2 2014 | $25,071,000 | +477.7% | 178,791 | +357.3% | 0.12% | +430.4% |
| Q1 2014 | $4,340,000 | – | 39,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |